Abbott today officially opened its new diabetes technology manufacturing facility in Kilkenny, Ireland. The site will employ ...

Abbott on Nov. 18 held a ceremony to celebrate the official opening of a state-of-the-art manufacturing facility in Kilkenny, ...

Abbott (NYSE:ABT) today announced a significant milestone abroad with the opening of a new manufacturing facility in Ireland.

The site is a global manufacturing centre of excellence for Abbott’s diabetes care business and will employ more than 800 ...

Abbott today marked the official opening of its state-of-the-art manufacturing facility in Kilkenny, Ireland with a ceremony ...

Abbott announces $100,000 grant to The Ireland Funds to support the education of young people from three DEIS schools located in Kilkenny ...

FreeStyle Libre CGMs, a breakthrough in diabetes care, actually started as a failed product — but key changes made it the ...

On World Diabetes Day, it's worth taking a look back at the last 10.5 months in the diabetes technology space.

But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...

Historically, providers would need to log into separate portals or support different workflows for each CGM manufacturer to review the data from their patients. Additionally, it was cumbersome to ...

Combine continuous glucose monitoring data from the FreeStyle Libre 2 system, from wherever you are*, along ... symptoms or expectations *Sensor is water-resistant in up to 1 meter (3 feet) of water.

However, the impact of combining GLP-1 RA therapy with FreeStyle Libre systems (FSL) has not been previously ... with a mean ...